Journal articles: 'Bifidobacterium lactis (Bb-12)'

1

Slačanac, V., M. Lučan, J. Hardi, V. Krstanović, and D. Koceva-Komlenić. "Fermentation of honey-sweetened soymilk with Bifidobacterium lactis Bb-12 and Bifidobacterium longum Bb-46: fermentation activity of bifidobacteria and in vitro antagonistic effect against Listeria monocytogenes FSL N1-017." Czech Journal of Food Sciences 30, No. 4 (June 13, 2012): 321–29. http://dx.doi.org/10.17221/190/2011-cjfs.

Full text

Abstract:

The influence of the honey addition on the fermentative activity of Bifidobacterium lactis Bb-12 and Bifidobacterium longum Bb-46 in soymilk was determined. Additionally, the inhibitory potential of honey-sweetened fermented soymilk against Listeria monocytogenes strain was examined. Two monofloral honey types were added to soymilk before the fermentation: dark-coloured chestnut honey and light-coloured acacia honey. On the basis of our previous studies on cow and goat milks, the basic hypothesis of this study was that the addition of honey could influence the growth of Bifidobacterium lactis and Bifidobacterium longum during the fermentation of soymilk. The addition of honey also influenced the decrease of raffinose and stachyose contents during fermentation. Furthermore, a higher inhibitory potential was assumed against Listeria monocytogenes caused by the honey addition. The obtained results show that both types of honey influenced the fermentative activity and numbers of Bifidobacterium lactis Bb-12 and Bifidobacterium longum Bb-46 viable cells in soymilk. Chestnut honey strongly influenced the acidity increase during the soymilk fermentation. A disc assay showed that the development of the inhibition zones of the growth depended on the type and concentration of honey, as well as on the type of milk. The chestnut honey had generally a higher inhibitory effect than acacia honey.  

APA, Harvard, Vancouver, ISO, and other styles

2

Torshin, I. Yu, O. A. Gromova, N. K. Tetruashvili, and A. L. Unanyan. "Synergistic interactions between bifidobacteria and vitamins for health support of a pregnant women and the fetus." Voprosy ginekologii, akušerstva i perinatologii 19, no. 5 (2020): 102–13. http://dx.doi.org/10.20953/1726-1678-2020-5-102-113.

Full text

Abstract:

Correction of the microbiota profile using prebiotics and probiotic strains of bifidobacteria and lactobacilli is important not only for the nutritional support during pregnancy, but also for the long-term health support of the mother and child. In this study, we performed systematic computer analysis of all available fundamental and clinical studies assessing interactions between probiotic bifidobacteria and various vitamins (B vitamins, vitamins A, C, E, D, etc.). We found that vitamins produce substantial amounts of vitamins (primarily folates and other B vitamins). Using the example of genome and proteome analysis of the probiotic strain BB-12 of Bifidobacterium lactis, we assessed molecular mechanisms underlying interactions of this strain with vitamins and trace elements. Key words: probiotics, microbiota, BB-12 strain of B. lactis, pregnancy, docosahexaenoic acid, vitamin D, folic acid, synergy of vitamins and bifidobacterial

APA, Harvard, Vancouver, ISO, and other styles

3

Van der Meulen, Roel, Tom Adriany, Kristof Verbrugghe, and Luc De Vuyst. "Kinetic Analysis of Bifidobacterial Metabolism Reveals a Minor Role for Succinic Acid in the Regeneration of NAD+ through Its Growth-Associated Production." Applied and Environmental Microbiology 72, no. 8 (August 2006): 5204–10. http://dx.doi.org/10.1128/aem.00146-06.

Full text

Abstract:

ABSTRACT Several strains belonging to the genus Bifidobacterium were tested to determine their abilities to produce succinic acid. Bifidobacterium longum strain BB536 and Bifidobacterium animalis subsp. lactis strain Bb 12 were kinetically analyzed in detail using in vitro fermentations to obtain more insight into the metabolism and production of succinic acid by bifidobacteria. Changes in end product formation in strains of Bifidobacterium could be related to the specific rate of sugar consumption. When the specific sugar consumption rate increased, relatively more lactic acid and less acetic acid, formic acid, and ethanol were produced, and vice versa. All Bifidobacterium strains tested produced small amounts of succinic acid; the concentrations were not more than a few millimolar. Succinic acid production was found to be associated with growth and stopped when the energy source was depleted. The production of succinic acid contributed to regeneration of a small part of the NAD+, in addition to the regeneration through the production of lactic acid and ethanol.

APA, Harvard, Vancouver, ISO, and other styles

4

Karaca, Oya, Nuray Güzeler, Hasan Tangüler, Kurban Yaşar, and Mutlu Akın. "Effects of Apricot Fibre on the Physicochemical Characteristics, the Sensory Properties and Bacterial Viability of Nonfat Probiotic Yoghurts." Foods 8, no. 1 (January 18, 2019): 33. http://dx.doi.org/10.3390/foods8010033.

Full text

Abstract:

In this study, the physical, chemical, rheological, and microbiological characteristics and the sensory properties of nonfat probiotic yoghurt produced at two different concentrations of apricot fibre (1% and 2%, w/v) and three different types of probiotic culture (Lactobacillus (L.) acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12 (Bifidobacterium BB-12), and their mixtures) were investigated. As the fibre content increased, the rheological, structural, and sensory properties of probiotic yoghurt were negatively affected, while counts of L. delbrueckii subsp. bulgaricus, L. acidophilus LA-5, and Bifidobacterium BB-12 increased. When all the results were evaluated, the best results were obtained by using L. acidophilus LA-5 as probiotic culture and adding 1% (w/v) apricot fibre.

APA, Harvard, Vancouver, ISO, and other styles

5

Abd El-Gawad, I. A., E. M. El-Sayed, S. A. Hafez, H. M. El-Zeini, and F. A. Saleh. "Inhibitory effect of yoghurt and soya yoghurt containing bifidobacteria on the proliferation of Ehrlich ascites tumour cells in vitro and in vivo in a mouse tumour model." British Journal of Nutrition 92, no. 1 (July 2004): 81–86. http://dx.doi.org/10.1079/bjn20041183.

Full text

Abstract:

The effect of yoghurt and soya yoghurt containing Bifidobacterium lactis Bb-12 or B. longum Bb-46 on Ehrlich ascites tumour cell proliferation was investigated in vitro and in vivo. Tumour cells were incubated with B. lactis Bb-12 or B. longum Bb-46 cultivated in de Mann Rogosa Sharpe (MRS) broth medium, or with their centrifuged supernatant fractions or sediments, for 2 h at 37°C. Treatment resulted in the inhibition of tumour cell proliferation by 85·42 (sd 0·78) and 85·10 (sd 1·28) % by intact micro-organisms, 77·61 (sd 0·29) and 71·43 (sd 1·75) % by their supernatant fractions, but only 4·00 (sd 0·19) and 9·09 (sd 1·24) % by the two sedimented bacteria, respectively. The incubation of tumour cells with yoghurt and soya yoghurt containing Bb-12 for 2 h resulted in 83·01 (sd 0·11) and 88·23 (sd 0·06) % inhibition, respectively, while it was 83·82 (sd 0·24) and 86·36 (sd 0·06) %, respectively for the same products containing Bb-46. Corresponding values for plain yoghurt and soya milk (without bifidobacteria) were 32·81 (sd 0·14) and 5·55 (sd 0·12) %, respectively. The differences between yoghurt or soya yoghurt containing Bb-12 or Bb-46 and plain yoghurt, soya milk or control treatments were statistically significant (n 3; P>0·05). Female Swiss albino mice were injected intraperitoneally with the same tumour cells. The lifespan of mice fed diets supplemented with yoghurt or soya yoghurt containing Bb-12 or Bb-46 was prolonged by 16, 23, 34 and 39%, respectively compared with that of the positive control group (n 6; P>0·05). The lifespan of groups fed plain yoghurt or soya milk was prolonged by 15 and 8%, respectively. Prolongation of lifespan was positively correlated with faeces bifidobacterial count in the groups fed yoghurt or soya yoghurt containing bifidobacteria (r 0·917; P>0·05).

APA, Harvard, Vancouver, ISO, and other styles

6

Znamirowska, Agata, Katarzyna Szajnar, and Małgorzata Pawlos. "Probiotic Fermented Milk with Collagen." Dairy 1, no. 2 (July 29, 2020): 126–34. http://dx.doi.org/10.3390/dairy1020008.

Full text

Abstract:

The aim of this study was to assess the possibility of using collagen protein hydrolysate in the production of milk fermented by Bifidobacterium animalis ssp. lactis Bb-12 and Lactobacillusrhamnosus. Physicochemical and organoleptic properties were studied and microbiological analysis of fermented milk was performed on days 1 and 21 of storage. Milk with the addition of 3% collagen protein hydrolysate was pasteurized (85 °C/30 min), divided into two groups, cooled to 37 °C and inoculated: the first group with Bifidobacteriumanimalis ssp. lactis Bb-12, second with Lactobacillus rhamnosus. Incubation was carried out at 37 °C/10 h. After 21 days of refrigerated storage, the pH value decreased in all analyzed milk samples. Collagen protein hydrolysate was a good milk additive to increase gel hardness and reduce syneresis. Moreover, its addition did not change the taste and odour of milk fermented with the use of Bifidobacterium Bb-12 and Lactobacillus rhamnosus. Collagen protein hydrolysate favourably stimulated the survival of Bifidobacterium Bb-12 during 21 days of storage. After 21 days of cold storage in milk with collagen, the number of Lactobacillus rhamnosus cells was reduced by 0.11 log cfu g−1.

APA, Harvard, Vancouver, ISO, and other styles

7

Yuan, Fahu, Yufei Liu, Qian Gui, Qiuyi Huang, Qianyu Li, Xuping Yang, Lixin Qiu, Jinmei Feng, and Xiji Shu. "Efficacy of Bifidobacterium animalis subsp. lactis BB-12 against Giardia duodenalis trophozoites: an experimental study." E3S Web of Conferences 233 (2021): 02048. http://dx.doi.org/10.1051/e3sconf/202123302048.

Full text

Abstract:

Giardia duodenalis, formerly known as Giardia lamblia, is an important zoonotic protozoan parasite. It mainly infects the intestines of humans, dogs, cats and domestic animals, causing diarrhea, abdominal pain, indigestion and weight loss. At present, all the clinical drugs for the treatment of Giardia have problems such as side effects and drug resistance to varying degrees, and the development of new drugs for the treatment of Giardia is still a hot issue. There is growing interest in using probiotics as an anti-intestinal parasite strategy. The present study aimed to assess the effect of supernatants of Bifidobacterium Animalis Subsp. lactis BB-12 on giardia the growth of giardia trophozoites. In this study, the Bifidobacterium animalis subsp. lactis BB-12 were cultured in BBL liquid medium, and the effects of the supernatants on the growth and adhesion of trophozoites of Giardia were observed. The results showed that the growth of Giardia flagellate was significantly inhibited by the supernatant. The influence of the supernatant on the morphology of the trophozoites was observed by microscope, and it was found that the surface of the trophozoites was uneven, the shape was atrophied, the surface cell membrane was broken to some extent, and the contents were spilt. In summary, the results of this study suggest that the fresh-cultured supernatants of the probiotic Bifidobacterium Animalis subsp. lactis BB-12 have anti-Giardia effects.

APA, Harvard, Vancouver, ISO, and other styles

8

Samane, Rahmdel, Jahed-Khaniki Gholamreza, Abdollahzadeh Seyedeh Maryam, Shekarforoush Seyed Shahram, and Mazloomi Seyed Mohammad. "Development of Fresh-cut Apple Slices Enriched with Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12." International Journal of Probiotics and Prebiotics 14, no. 1 (August 1, 2019): 37–44. http://dx.doi.org/10.37290/ijpp2641-7197.14:37-44.

Full text

Abstract:

This study was conducted to investigate the suitability of fresh-cut apple slices as carriers of the probiotic strain Bifidobacterium animalis subsp. lactis BB-12 (B. lactis BB-12). Furthermore, the effect of this strain against the colonization of apple by Escherichia coli O157:H7 was also evaluated. Apple wedges were suspended in an edible solution containing B. lactis BB-12 (greater than 8 log10 cfu mL–1) and/or E. coli O157:H7. Microbiological quality and physicochemical properties (pH, moisture content, soluble solids, titratable acidity, color, and texture) of probiotic samples were evaluated on days 1, 5, 9, and 14 of refrigerated storage. Sensory evaluation was performed on days 1 and 7. The probiotic concentration was above the recommended level of 10⁶ cfu/g during the test period. Co-inoculation with probiotic bacteria neither affected E. coli O157:H7 population dynamics, nor influenced the physicochemical and organoleptic properties of fresh-cut apple wedges. Minimally processed apples seem to be suitable vehicles for probiotic bacteria including B. lactis BB-12. Such probiotic products can be a desirable probiotic food choice for consumers, particularly those who are allergic or intolerant to dairy products. However, further studies are required to address the antagonistic effects of probiotic species on food-borne pathogens.

APA, Harvard, Vancouver, ISO, and other styles

9

Beitāne, Ilze, and Inga Ciproviča. "Nutritional Benefits of Bifidobacterium Lactis in Dairy Products." Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences 67, no. 4-5 (November 1, 2013): 378–82. http://dx.doi.org/10.2478/prolas-2013-0064.

Full text

Abstract:

Abstract Bifidobacteria are one of the most important probiotics in dairy products. They have positive effects on human health. Nutritional benefits of bifidobacteria are genetically determined and can be promoted with addition of prebiotics. The aim of the present study was to examine the properties of Bifidobacterium lactis in dairy products. Pasteurised milk, freeze-dried starter culture Bb-12 (Bifidobacterium lactis, Chr. Hansen, Denmark), syrup of lactulose (Duphalac®, the Netherlands), and inulin (“Raftiline®HP”, ORAFI, Belgium) were used in the experiments. The optimal concentrations of lactulose (2%) and inulin (4%) were established in preliminary studies, based on quality indices and nutritional value of fermented dairy products (Beitane, 2008). Amino acids, carbohydrates, such as lactose, lactulose and inulin, as well as cholesterol were determined during the study using appropriate analytical procedures. The enzymatic activity of bifidobacteria determines nutritional value of the fermented dairy products. Addition of 2% lactulose resulted in significant increase of some amino acid concentrations, such as leucine, phenylalanine, lysine and arginine concentrations (P < 0.05), compared with those in other treatments. The presence of prebiotics caused a decrease of cholesterol level by 35% and lactose content by 31% in fermented milk samples. The enzymatic activity of bifidobacteria should be promoted with addition of lactulose and inulin to increase nutritional value of functional dairy products.

APA, Harvard, Vancouver, ISO, and other styles

10

Leboš Pavunc, Andreja, Jasna Novak, Jagoda Šušković, Blaženka Kos, Ksenija Durgo, Ana Savić Mlakar, Krešo Bendelja, et al. "Influence of Dehydrated Wheat/Rice Cereal Matrices on Probiotic Activity of Bifidobacterium animalis ssp. lactis BB-12®." Food technology and biotechnology 57, no. 2 (2019): 147–58. http://dx.doi.org/10.17113/ftb.57.02.19.6142.

Full text

Abstract:

Three novel dehydrated wheat/rice cereal functional products with an addition of well documented probiotic Bifidobacterium animalis ssp. lactis BB-12® (BB-12®) were developed in Podravka factory for the infants older than 4 months: instant rice cereal, instant rice cereal with fruits and instant wheat cereal with vanilla. Notably, the number of viable BB-12® cells in each of the novel products was higher than the required minimal number of probiotic cells per gram of product (106 CFU/g) during the storage period of 106 weeks. Therefore, BB-12® strain recovery and genome stability were evaluated by strain-specific polimerase chain reaction and amplified fragment length polymorphism fingerprinting analysis. Further aim was to evaluate the influence of these three different cereal food matrices on specific probiotic properties of BB-12® strain in vitro. Applied food matrices positively influenced the survival in the simulated conditions of the gastrointestinal tract and antagonistic activity against undesirable microorganisms, while no influence on auto- and coaggregation ability of B. animalis ssp. lactis BB-12® was observed. Adhesion to extracellular matrix proteins and intestinal epithelial Caco-2 cells together with antibacterial activity emphasized competitive pathogen exclusion from Caco-2 cells by probiotic strain BB-12®.

APA, Harvard, Vancouver, ISO, and other styles

11

Zhang, Da-yong, Zheng-yang Pan, Xiong-kai Yu, Yi-fan Chen, Chen-hao Gao, Yu-tian Yang, Xue-fan Jiang, Na Li, and Jian-ping Pan. "Bifidobacterium lactis BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization." Journal of Immunology Research 2019 (December 19, 2019): 1–12. http://dx.doi.org/10.1155/2019/4657928.

Full text

Abstract:

Immunosenescence comprises a set of dynamic changes occurring in innate and adaptive immune systems, and macrophage aging plays an important role in innate and adaptive immunosenescence. However, function and polarization changes in aging macrophages have not been fully evaluated, and no effective method for delaying macrophage senescence is currently available. The results of this study reveal that D-galactose (D-gal) can promote J774A.1 macrophage senescence and induce macrophage M1 polarization differentiation. Bifidobacterium lactis BB-12 can significantly inhibit J774A.1 macrophage senescence induced by D-gal. IL-6 and IL-12 levels in the BB-12 groups remarkably decreased compared with that in the D-gal group, and the M2 marker, IL-10, and Arg-1 mRNA levels increased in the BB-12 group. BB-12 inhibited the expression of p-signal transducer and activator of transcription 1 (STAT1) and promoted p-STAT6 expression. In summary, the present study indicates that BB-12 can attenuate the J774A.1 macrophage senescence and induce M2 macrophage polarization, thereby indicating the potential of BB-12 to slow down immunosenescence and inflamm-aging.

APA, Harvard, Vancouver, ISO, and other styles

12

Pawlos, Małgorzata. "LOW-LACTOSE FERMENTED GOAT MILKS WITH BIFIDOBACTERIUM ANIMALIS SSP. LACTIS BB-12." Journal of Microbiology, Biotechnology and Food Sciences 9, no. 4 (February 2020): 751–55. http://dx.doi.org/10.15414/jmbfs.2020.9.4.751-755.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kowalczyk, Magdalena, Agata Znamirowska, and Magdalena Buniowska. "Probiotic Sheep Milk Ice Cream with Inulin and Apple Fiber." Foods 10, no. 3 (March 22, 2021): 678. http://dx.doi.org/10.3390/foods10030678.

Full text

Abstract:

The aim of the study was to assess the effect of the addition of inulin and the replacement of part of the inulin with apple fiber on the physicochemical and organoleptic properties of ice cream. Moreover, the survival of Bifidobacterium animalis ssp. Lactis Bb-12 and Lactobacillus rhamnosus was studied in sheep milk ice cream. There was no effect of the apple fiber and the type of bacteria on the number of bacteria in the probiotics after fermentation. As a result of freezing, in the mixture containing Bifidobacterium animalis ssp. Lactis Bb-12, there was a significant reduction in the bacteria from 0.39 log cfu g−1 to 0.46 log cfu g−1. In all of the ice cream on the 21st day of storage, it exceeded 10 log cfu g−1, which means that the ice cream retained the status of a probiotic product. The Lactobacillus rhamnosus ice cream showed a lower yellow color compared to the Bifidobacterium Bb-12 ice cream. The overrun of the sheep’s milk ice cream was within the range of 78.50% to 80.41%. The appearance of the sheep’s milk ice cream is influenced significantly by the addition of fiber and the type of bacteria and the interaction between the type of bacteria and the addition of fiber, and storage time and fiber.

APA, Harvard, Vancouver, ISO, and other styles

14

Odila Pereira, Joana, José Soares, Eduardo Costa, Sara Silva, Ana Gomes, and Manuela Pintado. "Characterization of Edible Films Based on Alginate or Whey Protein Incorporated with Bifidobacterium animalis subsp. lactis BB-12 and Prebiotics." Coatings 9, no. 8 (August 4, 2019): 493. http://dx.doi.org/10.3390/coatings9080493.

Full text

Abstract:

Recently, edible films were shown to be an effective strategy for the delivery of functional ingredients, such as probiotics and prebiotics. With that in mind, two soluble fibres (inulin and fructooligosaccharides) were selected as prebiotic elements, in whey protein isolate (WPI) and alginate (ALG) matrices plasticized with glycerol and used for the incorporation of Bifidobacterium animalis subsp. lactis BB-12. The results obtained showed that the viability of the B. animalis subsp. lactis BB-12 probiotic strain was maintained within the minimum threshold (106 CFU/g) necessary to act as a probiotic throughout 60 days of storage at 23 °C. The incorporation of prebiotic compounds improved B. animalis subsp. lactis BB-12 viability, with inulin showing the best performance, as it maintained the viability at 7.34 log CFU/g. The compositional characteristics (biopolymer type and prebiotics addition) of the film forming solutions had no significant impact upon the viability of the probiotic strain. The incorporation of probiotics and prebiotics did not modify the infrared spectra, revealing that the molecular structure of the films was not modified. The moisture content and water solubility decreased positively in WPI- and ALG-based films with the addition of prebiotics compounds. Overall, the results obtained in this work support the use of WPI films containing inulin as a good strategy to immobilize B. animalis subsp. lactis BB-12, with potential applications in the development of functional foods.

APA, Harvard, Vancouver, ISO, and other styles

15

MARTÍNEZ-VILLALUENGA, CRISTINA, JUANA FRÍAS, CONCEPCIÓN VIDAL-VALVERDE, and ROSARIO GÓMEZ. "Raffinose Family of Oligosaccharides from Lupin Seeds as Prebiotics: Application in Dairy Products." Journal of Food Protection 68, no. 6 (June 1, 2005): 1246–52. http://dx.doi.org/10.4315/0362-028x-68.6.1246.

Full text

Abstract:

The raffinose family of oligosaccharides (RFOs) isolated from lupin seeds (Lupinus albus var. Multolupa) was evaluated for bifidogenic effects during the manufacture of probiotic fermented milk. A mixed starter inoculum was composed of Bifidobacterium lactis Bb-12 and Lactobacillus acidophilus (1:1). Lupins are a rich source of RFOs that can be used as functional food ingredients. The addition of RFOs to milk increased B. lactis Bb-12 and L. acidophilus populations at the final fermentation time compared with controls. Final fermentation products are positively affected by addition of RFOs, and time of fermentation was reduced from 12 to 10 h. When RFOs were added to milk, they were preferentially used as a carbon source (57.7%) compared with lactose (23.7%) at the end of fermentation. These results suggest that the eventual choice of B. lactis Bb-12 and L. acidophilus in a mixed culture at a 1:1 ratio and addition of RFOs to produce a fermented milk product would have the advantages of rapid growth and acidification rate and would likely increase the probiotic effect of the final functional product.

APA, Harvard, Vancouver, ISO, and other styles

16

Tan, Tina P., Zhaoyong Ba, Mary E. Sanders, Frank J. D’Amico, Robert F. Roberts, Keisha H. Smith, and Daniel J. Merenstein. "Safety of Bifidobacterium animalis Subsp. Lactis (B. lactis) Strain BB-12-Supplemented Yogurt in Healthy Children." Journal of Pediatric Gastroenterology and Nutrition 64, no. 2 (February 2017): 302–9. http://dx.doi.org/10.1097/mpg.0000000000001272.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Garrigues, Christel, Eric Johansen, and Martin B. Pedersen. "Complete Genome Sequence of Bifidobacterium animalis subsp. lactis BB-12, a Widely Consumed Probiotic Strain." Journal of Bacteriology 192, no. 9 (February 26, 2010): 2467–68. http://dx.doi.org/10.1128/jb.00109-10.

Full text

Abstract:

ABSTRACT Bifidobacterium animalis subsp. lactis BB-12 is a commercially available probiotic strain used throughout the world in a variety of functional foods and dietary supplements. The benefits of BB-12 have been documented in a number of independent clinical trials. Determination of the complete genome sequence reveals a single circular chromosome of 1,942,198 bp with 1,642 predicted protein-encoding genes, 4 rRNA operons, and 52 tRNA genes. Knowledge of this sequence will lead to insight into the specific features which give this strain its probiotic properties.

APA, Harvard, Vancouver, ISO, and other styles

18

Jungersen, Mikkel, Anette Wind, Eric Johansen, Jeffrey Christensen, Birgitte Stuer-Lauridsen, and Dorte Eskesen. "The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12®." Microorganisms 2, no. 2 (March 28, 2014): 92–110. http://dx.doi.org/10.3390/microorganisms2020092.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Taipale, Teemu, Kaisu Pienihäkkinen, Erika Isolauri, Charlotte Larsen, Elke Brockmann, Pentti Alanen, Jorma Jokela, and Eva Söderling. "Bifidobacteriumanimalis subsp. lactis BB-12 in reducing the risk of infections in infancy." British Journal of Nutrition 105, no. 3 (September 24, 2010): 409–16. http://dx.doi.org/10.1017/s0007114510003685.

Full text

Abstract:

The impact of controlled administration of Bifidobacterium animalis subsp. lactis BB-12 (BB-12) on the risk of acute infectious diseases was studied in healthy newborn infants. In this double-blind, placebo-controlled study, 109 newborn 1-month-old infants were assigned randomly to a probiotic group receiving a BB-12-containing tablet (n 55) or to a control group receiving a control tablet (n 54). Test tablets were administered to the infants twice a day (daily dose of BB-12 10 billion colony-forming units) from the age of 1–2 months to 8 months with a novel slow-release pacifier or a spoon. Breastfeeding habits, pacifier use, dietary habits, medications and all signs and symptoms of acute infections were registered. At the age of 8 months, faecal samples were collected for BB-12 determination (quantitative PCR method). The baseline characteristics of the two groups were similar, as was the duration of exclusive breastfeeding. BB-12 was recovered (detection limit log 5) in the faeces of 62 % of the infants receiving the BB-12 tablet. The daily duration of pacifier sucking was not associated with the occurrence of acute otitis media. No significant differences between the groups were observed in reported gastrointestinal symptoms, otitis media or use of antibiotics. However, the infants receiving BB-12 were reported to have experienced fewer respiratory infections (65 v. 94 %; risk ratio 0·69; 95 % CI 0·53, 0·89; P = 0·014) than the control infants. Controlled administration of BB-12 in early childhood may reduce respiratory infections.

APA, Harvard, Vancouver, ISO, and other styles

20

Nishiyama, Kyoko, Takahiro Kobayashi, Yuko Sato, Yoshihisa Watanabe, Riki Kikuchi, Ryoko Kanno, Tetsuo Koshizuka, Nozomu Miyazaki, Ken Ishioka, and Tatsuo Suzutani. "A Double-Blind Controlled Study to Evaluate the Effects of Yogurt Enriched with Lactococcus lactis 11/19-B1 and Bifidobacterium lactis on Serum Low-Density Lipoprotein Level and Antigen-Specific Interferon-γ Releasing Ability." Nutrients 10, no. 11 (November 16, 2018): 1778. http://dx.doi.org/10.3390/nu10111778.

Full text

Abstract:

In order to clarify the effects of the Lactococcus lactis (L. lactis) 11/19-B1 strain, a double-blind controlled study of yogurt fermented with the strain was carried out. For the study, two kinds of yogurt, the control and test yogurt, were prepared; the control yogurt was fermented with Streptococcus thermophiles, Lactobacillus delbrueckii subspecies bulgaricus, and Lactobacillus acidophilus, and the test yogurt was enriched with L. lactis 11/19-B1 and Bifidobacterium lactis (B. lactis) BB-12 strains. Seventy-six volunteers who had not received treatment with pharmaceuticals were randomly divided into two groups with each group ingesting 80 g of either the test or control yogurt every day for 8 weeks. Before and after yogurt intake, fasting blood was taken and blood sugar, blood lipids, and anti-cytomegalovirus cellular immunity were estimated. In the test yogurt group, low-density lipoprotein (LDL) was significantly decreased (159.1 ± 25.7 to 149.3 ± 24.4; p = 0.02), but this effect was not observed in the control yogurt group. When the test yogurt group was divided into two groups based on LDL levels of over or under 120 mg/dL, this effect was only observed in the high LDL group. No LDL-lowering effect of B. lactis BB-12 strain was previously reported; therefore, the hypocholesterolemic effects observed in this study are thought to be caused by the L. lactis 11/19-B1 strain alone or its combination with the B. lactis BB-12 strain.

APA, Harvard, Vancouver, ISO, and other styles

21

Merenstein, Daniel, Claire M. Fraser, Robert F. Roberts, Tian Liu, Silvia Grant-Beurmann, Tina P. Tan, Keisha Herbin Smith, et al. "Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome." Nutrients 13, no. 8 (August 17, 2021): 2814. http://dx.doi.org/10.3390/nu13082814.

Full text

Abstract:

The administration of broad-spectrum antibiotics is often associated with antibiotic-associated diarrhea (AAD), and impacts gastrointestinal tract homeostasis, as evidenced by the following: (a) an overall reduction in both the numbers and diversity of the gut microbiota, and (b) decreased short-chain fatty acid (SCFA) production. Evidence in humans that probiotics may enhance the recovery of microbiota populations after antibiotic treatment is equivocal, and few studies have addressed if probiotics improve the recovery of microbial metabolic function. Our aim was to determine if Bifidobacterium animalis subsp. lactis BB-12 (BB-12)-containing yogurt could protect against antibiotic-induced fecal SCFA and microbiota composition disruptions. We conducted a randomized, allocation-concealed, controlled trial of amoxicillin/clavulanate administration (days 1–7), in conjunction with either BB-12-containing or control yogurt (days 1–14). We measured the fecal levels of SCFAs and bacterial composition at baseline and days 7, 14, 21, and 30. Forty-two participants were randomly assigned to the BB-12 group, and 20 participants to the control group. Antibiotic treatment suppressed the fecal acetate levels in both the control and probiotic groups. Following the cessation of antibiotics, the fecal acetate levels in the probiotic group increased over the remainder of the study and returned to the baseline levels on day 30 (−1.6% baseline), whereas, in the control group, the acetate levels remained suppressed. Further, antibiotic treatment reduced the Shannon diversity of the gut microbiota, for all the study participants at day 7. The magnitude of this change was larger and more sustained in the control group compared to the probiotic group, which is consistent with the hypothesis that BB-12 enhanced microbiota recovery. There were no significant baseline clinical differences between the two groups. Concurrent administration of amoxicillin/clavulanate and BB-12 yogurt, to healthy subjects, was associated with a significantly smaller decrease in the fecal SCFA levels and a more stable taxonomic profile of the microbiota over time than the control group.

APA, Harvard, Vancouver, ISO, and other styles

22

Van den Abbeele, Pieter, Cindy Duysburgh, Jonas Ghyselinck, Shellen Goltz, Yulia Berezhnaya, Thomas Boileau, Anke De Blaiser, and Massimo Marzorati. "Fructans with Varying Degree of Polymerization Enhance the Selective Growth of Bifidobacterium animalis subsp. lactis BB-12 in the Human Gut Microbiome In Vitro." Applied Sciences 11, no. 2 (January 9, 2021): 598. http://dx.doi.org/10.3390/app11020598.

Full text

Abstract:

Synbiotics aim to improve gastrointestinal health by combining pre- and probiotics. This study evaluated combinations of Bifidobacterium animalis subsp. lactis BB-12 with seven fructans: oligofructoses (OF1-OF2; low degree of polymerization (DP)), inulins (IN1-IN2-IN3; high DP) and OF/IN mixtures (OF/IN1-OF/IN2). During monoculture incubations, all fructans were fermented by BB-12 as followed from increased BB-12 numbers and increased acetate and lactate concentrations, with most pronounced fermentation for low DP fructans (OF1-OF2). Further, short-term colonic incubations for three human donors revealed that also in presence of a complex microbiota, all fructans (particularly OF1) consistently selectively enhanced the growth of BB-12. While each fructan as such already increased Bifidobacteriaceae numbers with 0.94–1.26 log(cells/mL), BB-12 co-supplementation additionally increased Bifidobacteriaceae with 0.17–0.46 log(cells/mL). Further, when co-supplemented with fructans, BB-12 decreased Enterobacteriaceae numbers (significant except for IN1-IN3). At metabolic level, all fructans decreased pH due to increased acetate and lactate production, while OF/IN2-IN1-IN2-IN3 also stimulated propionate and butyrate production. BB-12 co-supplementation further increased propionate and butyrate for OF/IN2-IN3 and IN1-IN2, respectively. Overall, combinations of BB-12 with fructans are promising synbiotic concepts, likely due to intracellular consumption of low DP-fructans by BB-12 (either present in starting product or released upon fermentation by indigenous microbes), thereby enhancing effects of the co-administered fructan.

APA, Harvard, Vancouver, ISO, and other styles

23

Van den Abbeele, Pieter, Cindy Duysburgh, Jonas Ghyselinck, Shellen Goltz, Yulia Berezhnaya, Thomas Boileau, Anke De Blaiser, and Massimo Marzorati. "Fructans with Varying Degree of Polymerization Enhance the Selective Growth of Bifidobacterium animalis subsp. lactis BB-12 in the Human Gut Microbiome In Vitro." Applied Sciences 11, no. 2 (January 9, 2021): 598. http://dx.doi.org/10.3390/app11020598.

Full text

Abstract:

Synbiotics aim to improve gastrointestinal health by combining pre- and probiotics. This study evaluated combinations of Bifidobacterium animalis subsp. lactis BB-12 with seven fructans: oligofructoses (OF1-OF2; low degree of polymerization (DP)), inulins (IN1-IN2-IN3; high DP) and OF/IN mixtures (OF/IN1-OF/IN2). During monoculture incubations, all fructans were fermented by BB-12 as followed from increased BB-12 numbers and increased acetate and lactate concentrations, with most pronounced fermentation for low DP fructans (OF1-OF2). Further, short-term colonic incubations for three human donors revealed that also in presence of a complex microbiota, all fructans (particularly OF1) consistently selectively enhanced the growth of BB-12. While each fructan as such already increased Bifidobacteriaceae numbers with 0.94–1.26 log(cells/mL), BB-12 co-supplementation additionally increased Bifidobacteriaceae with 0.17–0.46 log(cells/mL). Further, when co-supplemented with fructans, BB-12 decreased Enterobacteriaceae numbers (significant except for IN1-IN3). At metabolic level, all fructans decreased pH due to increased acetate and lactate production, while OF/IN2-IN1-IN2-IN3 also stimulated propionate and butyrate production. BB-12 co-supplementation further increased propionate and butyrate for OF/IN2-IN3 and IN1-IN2, respectively. Overall, combinations of BB-12 with fructans are promising synbiotic concepts, likely due to intracellular consumption of low DP-fructans by BB-12 (either present in starting product or released upon fermentation by indigenous microbes), thereby enhancing effects of the co-administered fructan.

APA, Harvard, Vancouver, ISO, and other styles

24

Guerrero Alva, Daniza Mirtha, and Gerardo Gamarra Ballena. "Producción de leche fermentada utilizando bacterias probióticas (Lactobacillus acidophilus, Bifidobacterium lactís y Streptococcus thermophilus) con leche de cabra y de vaca." Ciencia e Investigación 9, no. 1 (June 19, 2006): 15–25. http://dx.doi.org/10.15381/ci.v9i1.4973.

Full text

Abstract:

En el presente estudio se adicionó un cultivo mixto Bio Rich constituido por Lactobacillus acidophilus La-1,Bifidobacterium lactis Bb-12 y Streptococcus thermophilus a leche de cabra, de vaca, así como a la mezcla de ambas en proporción (1:1); obteniéndose leche fermentada o cultivada entera o integral en base al contenido de acidez, porcentaje de grasa y al crecimiento de las bacterias probióticas Lactobacillus acidophi1us (107ufc/ml) y Bifidobacterium lactis (106ufc/ml), además de Streptococcus thermophilus (109ufc/ml), las que cumplen las normas microbiológicas de las leches fermentadas o cultivadas. Se determinó el porcentaje de inóculo y la temperatura de fermentación, siendo el pH de corte de 4,5. El tiempo de proceso con leche de vaca, de cabra y con la mezcla de leche de cabra y de vaca (1 :1) fue de 4 horas, 7 horas y 4 horas, respectivamente.

APA, Harvard, Vancouver, ISO, and other styles

25

Znamirowska, Agata, Magdalena Buniowska, and Piotr Kuźniar. "WZBOGACANIE MLECZANEM MAGNEZU I WAPNIA MLECZNYCH NAPOJÓW FERMENTOWANYCH PRZEZ BIFIDOBACTERIUM ANIMALIS SSP. LACTIS Bb-12." Zeszyty Problemowe Postępów Nauk Rolniczych, no. 592 (March 1, 2018): 107–17. http://dx.doi.org/10.22630/zppnr.2018..592.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Znamirowska, Agata, Magdalena Buniowska, and Piotr Kuźniar. "WZBOGACANIE MLECZANEM MAGNEZU I WAPNIA MLECZNYCH NAPOJÓW FERMENTOWANYCH PRZEZ BIFIDOBACTERIUM ANIMALIS SSP. LACTIS Bb-12." Zeszyty Problemowe Postępów Nauk Rolniczych, no. 592 (March 1, 2018): 107–17. http://dx.doi.org/10.22630/zppnr.2018.592.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Szajewska, Hania, and Iva Hojsak. "Health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12 in children." Postgraduate Medicine 132, no. 5 (February 26, 2020): 441–51. http://dx.doi.org/10.1080/00325481.2020.1731214.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Gilad, Ofir, Karin Hjernø, Eva C. Østerlund, Abelardo Margolles, Birte Svensson, Birgitte Stuer-Lauridsen, Anders L. Blom Møller, and Susanne Jacobsen. "Insights into physiological traits of Bifidobacterium animalis subsp. lactis BB-12 through membrane proteome analysis." Journal of Proteomics 75, no. 4 (February 2012): 1190–200. http://dx.doi.org/10.1016/j.jprot.2011.10.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Taipale, Teemu J., Kaisu Pienihäkkinen, Erika Isolauri, Jorma T. Jokela, and Eva M. Söderling. "Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood." Pediatric Research 79, no. 1 (September 15, 2015): 65–69. http://dx.doi.org/10.1038/pr.2015.174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Mitsuma, Takashi, Hiroko Odajima, Zyunko Momiyama, Kana Watanabe, Misako Masuguchi, Takashi Sekine, Satoshi Shidara, and Shigeki Hirano. "Enhancement of gene expression by a peptide p(CHWPR) produced by Bifidobacterium lactis BB-12." Microbiology and Immunology 52, no. 3 (March 2008): 144–55. http://dx.doi.org/10.1111/j.1348-0421.2008.00022.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Yeo, A. Y. Y., M. Z. Toh, and S. Q. Liu. "Enhancement of bifidobacteria survival by Williopsis saturnus var. saturnus in milk." Beneficial Microbes 7, no. 1 (February 1, 2016): 135–44. http://dx.doi.org/10.3920/bm2015.0012.

Full text

Abstract:

The viability of three strains of probiotic Bifidobacterium lactis that were inoculated into UHT milk was examined with and without the presence of the yeast, Williopsis saturnus var. saturnus NCYC 22, in polypropylene tubes at 30 °C. The B. lactis viable cell count for strains HN019 and BB-12 remained above 6.0 Log cfu/ml, while strain B94 had 5.7 Log cfu/ml after six weeks of incubation in the presence of the co-inoculated yeast. Incubating the bifidus milk without added yeast under anaerobic condition did not improve the survival of B. lactis HN019, indicating that oxygen removal may not be responsible for W. saturnus NCYC 22’s viability enhancing property. The addition of yeast supernatant or non-viable yeast also did not show any stabilising effects, suggesting that physical contact and/or interaction between viable W. saturnus and B. lactis plays an important role in sustaining the viability of the probiotic. W. saturnus NCYC 22 could increase the survival of B. lactis in bifidus milk under ambient temperature regardless of the initial concentration of yeast cells inoculated due to yeast growth. This study demonstrated the viability enhancing effect of viable W. saturnus NCYC 22 on B. lactis HN019, which could help towards extending the shelf-life of dairy beverages containing probiotic bifidobacteria.

APA, Harvard, Vancouver, ISO, and other styles

32

Dzottsoeva, E. S., and A. V. Gorelov. "Monostrain and multistrain probiotics for respiratory diseases in children." Russian Medical Inquiry 4, no. 11 (2020): 698–704. http://dx.doi.org/10.32364/2587-6821-2020-4-11-698-704.

Full text

Abstract:

Acute respiratory infections (ARIs) in children are common conditions characterized by high morbidity. ARIs account for up to 75% of all cases of antibiotic use. Dysbiosis results in the impaired performance of vital functions, i.e., digestion, synthesis, colonization resistance, and the regulation of immune system. Probiotics are one of the effective tools to affect the composition of gut microbiota and to restore its metabolic activity. Probiotics, their effects on human organism, and their use in various diseases have received an enormous attention. Meanwhile, the use of antibiotics and the etiological diversity of ARIs account for the lack and irrationality of extensive preventive measures (as in flu) and raise the interest in non-specific prophylaxis. Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis subsp. Lactis BB-12 are well-studied strains. Lactobacillus plantarum LP01 and LP02, Lactobacillus rhamnosus LR04 and LR05, and Bifidobacterium lactis BS01 used as monostrain probiotics are also of interest. Multistrain probiotics are gaining traction. However, these probiotics are understudied and require more attention. KEYWORDS: microbiome, monostrain probiotics, multistrain probiotics, acute respiratory infections, antibiotic-associated diarrhea, antibiotic-associated syndrome, Lactobacillus rhamnosus, Bifidobacterium lactis. FOR CITATION: Dzottsoeva E.S., Gorelov A.V. Monostrain and multistrain probiotics for respiratory diseases in children. Russian Medical Inquiry. 2020;4(11):698–704. DOI: 10.32364/2587-6821-2020-4-11-698-704.

APA, Harvard, Vancouver, ISO, and other styles

33

Castro-Herrera, Vivian M., Christine Rasmussen, Anja Wellejus, Elizabeth A. Miles, and Philip C. Calder. "In Vitro Effects of Live and Heat-Inactivated Bifidobacterium animalis Subsp. Lactis, BB-12 and Lactobacillus rhamnosus GG on Caco-2 Cells." Nutrients 12, no. 6 (June 8, 2020): 1719. http://dx.doi.org/10.3390/nu12061719.

Full text

Abstract:

Probiotic–host interaction can be cell-to-cell or through metabolite production. Dead (inactive) organisms could interact with the host, leading to local effects and possible health benefits. This research examined the effects of live and heat-inactivated Bifidobacterium animalis subsp. lactis, BB-12 (BB-12) and Lactobacillus rhamnosus GG (LGG) on cultured Caco-2 cells focusing on epithelial integrity and production of inflammatory mediators. Live organisms increased transepithelial electrical resistance (TEER), a barrier-integrity marker, with LGG having a greater effect than BB-12. When mildly heat-treated, both organisms had a more modest effect on TEER than when alive. When they were heat-inactivated, both organisms had only a limited effect on TEER. Neither live nor heat-inactivated organisms affected production of six inflammatory mediators produced by Caco-2 cells compared to control conditions. Pre-treatment with heat-inactivated LGG or BB-12 did not alter the decline in TEER caused by exposure to an inflammatory cocktail of cytokines. However, pre-treatment of Caco-2 cells with heat-inactivated organisms alone or their combination decreased the production of interleukin (IL)-6, IL-18, and vascular endothelial growth factor. To conclude, while the live organisms improve the epithelial barrier using this model, neither live nor heat-inactivated organisms directly elicit an inflammatory response by the epithelium. Pre-treatment with heat-inactivated BB-12 or LGG can reduce some components of the response induced by an inflammatory stimulus.

APA, Harvard, Vancouver, ISO, and other styles

34

Gilad, Ofir, Susanne Jacobsen, Birgitte Stuer-Lauridsen, Martin Bastian Pedersen, Christel Garrigues, and Birte Svensson. "Combined Transcriptome and Proteome Analysis of Bifidobacterium animalis subsp. lactis BB-12 Grown on Xylo-Oligosaccharides and a Model of Their Utilization." Applied and Environmental Microbiology 76, no. 21 (September 17, 2010): 7285–91. http://dx.doi.org/10.1128/aem.00738-10.

Full text

Abstract:

ABSTRACT Recent studies have demonstrated that xylo-oligosaccharides (XOS), which are classified as emerging prebiotics, selectively enhance the growth of bifidobacteria in general and of B ifidobacterium animalis subsp. lactis strains in particular. To elucidate the metabolism of XOS in the well-documented and widely used probiotic strain B. animalis subsp. lactis BB-12, a combined proteomic and transcriptomic approach was applied, involving DNA microarrays, real-time quantitative PCR (qPCR), and two-dimensional difference gel electrophoresis (2D-DIGE) analyses of samples obtained from cultures grown on either XOS or glucose. The analyses show that 9 of the 10 genes that encode proteins predicted to play a role in XOS catabolism (i.e., XOS-degrading and -metabolizing enzymes, transport proteins, and a regulatory protein) were induced by XOS at the transcriptional level, and the proteins encoded by three of these (β-d-xylosidase, sugar-binding protein, and xylose isomerase) showed higher abundance on XOS. Based on the obtained results, a model for the catabolism of XOS in BB-12 is suggested, according to which the strain utilizes an ABC (ATP-binding cassette) transport system (probably for oligosaccharides) to bind XOS on the cell surface and transport them into the cell. XOS are then degraded intracellularly through the action of xylanases and xylosidases to d-xylose, which is subsequently metabolized by the d-fructose-6-P shunt. The findings obtained in this study may have implications for the design of a synbiotic application containing BB-12 and the XOS used in the present study.

APA, Harvard, Vancouver, ISO, and other styles

35

Hyrslova, Ivana, Gabriela Krausova, Jana Smolova, Barbora Stankova, Tomas Branyik, Hana Malinska, Martina Huttl, Antonin Kana, Ladislav Curda, and Ivo Doskocil. "Functional Properties of Chlorella vulgaris, Colostrum, and Bifidobacteria, and Their Potential for Application in Functional Foods." Applied Sciences 11, no. 11 (June 6, 2021): 5264. http://dx.doi.org/10.3390/app11115264.

Full text

Abstract:

The market for new functional foods and food supplements is rapidly evolving, with a current emphasis on using natural sources. Algae, probiotics, and colostrum are rich sources of nutrients and bioactive compounds with positive effects on human and animal health. To determine the potential for developing new functional foods combining these components, we evaluated their synergistic effects. We assessed the growth of selected bifidobacteria in a medium supplemented with Chlorella vulgaris and its immunomodulatory and cytotoxic effects on the human peripheral mononuclear cells and colon cancer cell lines Caco-2 and HT29. The hypocholesterolemic effects of Chlorella powder and bovine colostrum fermented by Bifidobacterium animalis subsp. lactis BB12® on lipid metabolism in rats fed a high-fat diet were also determined. Chlorella addition promoted Bifidobacteria growth, with significantly increased inflammatory cytokine (TNF-α and IL-6) levels following 1.0% (w/v) Chlorella stimulation. Rats fed diets containing fermented colostrum with 0.5% (w/v) added Chlorella powder exhibited significantly decreased triglyceride, very low-density lipoprotein, and alanine and aspartate aminotransferase levels, compared to those of the control group. These results support that C. vulgaris is not cytotoxic in intestinal cell models and affords prebiotic and immunomodulatory effects, as well as synergistic triglyceride-lowering effects with bovine colostrum and B. animalis subsp. lactis BB-12.

APA, Harvard, Vancouver, ISO, and other styles

36

Szajnar, Katarzyna, Agata Znamirowska, and Dorota Kalicka. "Effects of various magnesium salts for the production of milk fermented by Bifidobacterium animalis ssp. lactis Bb-12." International Journal of Food Properties 22, no. 1 (January 1, 2019): 1087–99. http://dx.doi.org/10.1080/10942912.2019.1628779.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Gilad, Ofir, Birte Svensson, Alexander H. Viborg, Birgitte Stuer-Lauridsen, and Susanne Jacobsen. "The extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12 reveals proteins with putative roles in probiotic effects." PROTEOMICS 11, no. 12 (May 20, 2011): 2503–14. http://dx.doi.org/10.1002/pmic.201000716.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Burak Çınar, Şenay, Gülşah Çalışkan Koç, Safiye Nur Dirim, Gülfem Ünal, and Ayşe Sibel Akalın. "Textural and sensorial characteristics of set-type yogurt containing Bifidobacterium animalis subsp. lactis Bb-12 and quince powder." Journal of Food Measurement and Characterization 14, no. 6 (July 12, 2020): 3067–77. http://dx.doi.org/10.1007/s11694-020-00552-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hyrslova, Ivana, Gabriela Krausova, Jana Smolova, Barbora Stankova, Tomas Branyik, Hana Malinska, Martina Huttl, Antonin Kana, Ivo Doskocil, and Ladislav Curda. "Prebiotic and Immunomodulatory Properties of the Microalga Chlorella vulgaris and Its Synergistic Triglyceride-Lowering Effect with Bifidobacteria." Fermentation 7, no. 3 (July 22, 2021): 125. http://dx.doi.org/10.3390/fermentation7030125.

Full text

Abstract:

The microalga Chlorella and strains of Bifidobacterium have been used in human or animal food supplements for decades because of their positive health effects. The presented study assessed different properties of C. vulgaris and its combination with bifidobacteria with the aim to develop new functional foods. The growth of four bifidobacteria strains in milk and whey supplemented with 1.0% (w/v) C. vulgaris and the immunomodulatory effects of aqueous Chlorella solutions (0.5%, 1.0%, and 3.0%) on human peripheral mononuclear cells were evaluated. Furthermore, synergistic effects on lipid metabolism of rats fed a high-fat diet with Chlorella and B. animalis subsp. lactis BB-12® were analysed. Chlorella had a positive growth-promoting effect on the tested bifidobacteria (p < 0.05), and significantly increased the secretion of inflammatory cytokines (tumor necrosis factor-α, interleukin-10, and interleukin-6), depending on the concentration of Chlorella (p < 0.05). After 8 weeks, significant synergistic effects of Chlorella and bifidobacteria on triglyceride levels in rat heart, liver, and serum were observed (p < 0.05). These results demonstrate that various combinations of Chlorella and bifidobacteria have significant potential for the development of new fermented products, dependent on the algal species, probiotic strain, application form, and concentrations for acceptable sensory quality for consumers.

APA, Harvard, Vancouver, ISO, and other styles

40

Merenstein, DJ, TP Tan, KA Herbin Smith, RF Roberts, and FJ D’Amico. "PO-0378 Safety Of Bifidobacterium Animalis Subsp. Lactis (b. Lactis) Strain Bb-12-supplemented Yoghourt In Healthy Children: A Phase I Safety Study." Archives of Disease in Childhood 99, Suppl 2 (October 2014): A369.1—A369. http://dx.doi.org/10.1136/archdischild-2014-307384.1024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

MALINEN, E., J. MATTO, M. SALMITIE, M. ALANDER, M. SAARELA, and A. PALVA. "PCR-ELISAII: Analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation." Systematic and Applied Microbiology 25, no. 2 (2002): 249–58. http://dx.doi.org/10.1016/s0723-2020(04)70109-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Gorbunov, S. G. "Probiotics in rehabilitation of children after acute intestinal infections." Voprosy detskoj dietologii 18, no. 5 (2020): 30–35. http://dx.doi.org/10.20953/1727-5784-2020-5-30-35.

Full text

Abstract:

The article contains information about how often and why acute intestinal infections in children can have adverse outcomes, describes their clinical picture and the pathogenetic basis of development. The significance of an impaired microbiota in the development of post-infectious functional disorders of the gastrointestinal tract in childhood is emphasized. Data are presented on the beneficial properties of functional food products containing probiotic strains of Bifidobacterium animalis subspecies lactis BB-12 and Lactobacillus acidophilus LA-5, the use of which makes it possible to correct the imbalance in the gut microbiota and to manage intestinal dysfunction, thus ensuring rehabilitation of patients. Key words: dysbiosis, microbiota, acute intestinal infections, probiotics, rehabilitation, functional nutrition

APA, Harvard, Vancouver, ISO, and other styles

43

Champagne, C. P., Y. Raymond, J. Gonthier, and P. Audet. "Enumeration of the contaminating bacterial microbiota in unfermented pasteurized milks enriched with probiotic bacteria." Canadian Journal of Microbiology 55, no. 4 (April 2009): 410–18. http://dx.doi.org/10.1139/w08-151.

Full text

Abstract:

Pasteurized and unfermented milks supplemented with probiotic bacteria are appearing on the market. It then becomes a challenge to ascertain the undesirable contamination microbiota in the presence of a largely superior population of probiotic bacteria. A method to enumerate the contaminating microbial microbiota in such probiotic-enriched milks was developed. The probiotic cultures, Lactobacillus rhamnosus Lb-Immuni-T™ and Bifidobacterium animalis subsp. lactis BB-12®, were added to a pasteurized unfermented milk to reach a minimum of 1 billion CFU per 250 mL portion, as ascertained by plating on de Man – Rogosa – Sharpe (MRS) agar in anaerobic conditions. No growth of B. animalis subsp. lactis BB-12 was noted on plate count agar (PCA) or Petrifilm™ plates, and the presence of this culture did not affect standard plate counts (SPC) of contaminating bacteria. However, L. rhamnosus formed colonies on PCA and Petrifilm™ plates. Attempts were thus made to inhibit the growth of the probiotic lactobacilli in PCA. The addition of 2% sodium phosphate (SP) or 5% glycerophosphate (GP) inhibited the growth of the lactobacilli in broths, but pin-point colonies of L. rhamnosus Lb-Immuni-T nevertheless appeared on PCA supplemented with phosphates. SPC could be obtained on PCA + 2% SP by only counting the large colonies, but this resulted in a significant (4.4 fold) underestimation of SPC values. On Petrifilm™ AC, at dilutions 0 to 2, all colonies were considered as being contaminants, while at dilutions 3 and 4, only large colonies were counted for SPC determinations. There was a direct correlation (R2 = 0.99) between SPC values with Petrifilm™ in uninoculated milks and those obtained on probiotic-enriched milks. The high correlation obtained over the 102 to 106 CFU/mL range of SPC values show that this Petrifilm™ method is appropriate to evaluate the microbiological quality of pasteurized milks enriched with L. rhamnosus Lb-Immuni-T and B. animalis subsp. lactis BB-12.

APA, Harvard, Vancouver, ISO, and other styles

44

MAGARIÑOS, HAROLDO, SADE SELAIVE, MARCIA COSTA, MIRTZA FLORES, and OLIVIA PIZARRO. "Viability of probiotic micro-organisms (Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis Bb-12) in ice cream." International Journal of Dairy Technology 60, no. 2 (May 2007): 128–34. http://dx.doi.org/10.1111/j.1471-0307.2007.00307.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Yerlikaya, Oktay, Derya Saygili, and Asli Akpinar. "An application of selected enterococci using Bifidobacterium animalis subsp. lactis BB-12 in set-style probiotic yoghurt-like products." Food Bioscience 41 (June 2021): 101096. http://dx.doi.org/10.1016/j.fbio.2021.101096.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Banach, Katarzyna, Paweł Glibowski, and Paulina Jedut. "The Effect of Probiotic Yogurt Containing Lactobacillus Acidophilus LA-5 and Bifidobacterium Lactis BB-12 on Selected Anthropometric Parameters in Obese Individuals on an Energy-Restricted Diet: A Randomized, Controlled Trial." Applied Sciences 10, no. 17 (August 23, 2020): 5830. http://dx.doi.org/10.3390/app10175830.

Full text

Abstract:

Previous studies using probiotics have shown strain-dependent effects on body mass index (BMI), body mass, or fat mass (FM). The aim of this study was to evaluate how the addition of yogurt containing Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 strains to a diet plan affects selected anthropometric parameters in obese people on an energy-restricted diet. Fifty-four subjects aged 20–49 (34.52 ± 9.58) years were included in this study. The recruited subjects were assigned to two subgroups: consuming probiotic yogurt along with a hypocaloric diet (GP) (n–27) or the same diet but without an intentional introduction of yogurt (GRD) (n–27) for 12 weeks. Both GP and GRD decreased body weight, BMI, fat mass and visceral fat by 5.59 kg and 4.71 kg, 1.89 and 1.61 kg/m2, 4.80 kg and 4.07 kg, and 0.68 and 0.65 L, respectively, although the obtained differences were not significant. Analysis of GP and GRD results separately at the beginning and end of the intervention showed that fat loss was substantial in both groups (p < 0.05). Consumption of yogurt containing LA-5 and BB-12 does not significantly improve anthropometric parameters in obese patients.

APA, Harvard, Vancouver, ISO, and other styles

47

Rizzardini, Giuliano, Dorte Eskesen, Philip C. Calder, Amedeo Capetti, Lillian Jespersen, and Mario Clerici. "Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study." British Journal of Nutrition 107, no. 6 (September 7, 2011): 876–84. http://dx.doi.org/10.1017/s000711451100420x.

Full text

Abstract:

The present study investigated the ability of Bifidobacterium animalis ssp. lactis (BB-12®) and Lactobacillus paracasei ssp. paracasei (L. casei 431®) to modulate the immune system using a vaccination model in healthy subjects. A randomised, double-blind, placebo-controlled, parallel-group study was conducted in 211 subjects (56 % females, mean age 33·2 (sd 13·1) years). Subjects consumed a minimum of 109 colony-forming units of BB-12® (capsule) or L. casei 431® (dairy drink) or a matching placebo once daily for 6 weeks. After 2 weeks, a seasonal influenza vaccination was given. Plasma and saliva samples were collected at baseline and after 6 weeks for the analysis of antibodies, cytokines and innate immune parameters. Changes from baseline in vaccine-specific plasma IgG, IgG1 and IgG3 were significantly greater in both probiotic groups v. the corresponding placebo group (L. casei 431®, P = 0·01 for IgG; P < 0·001 for remaining comparisons). The number of subjects obtaining a substantial increase in specific IgG (defined as ≥ 2-fold above baseline) was significantly greater in both probiotic groups v. placebo (BB-12®, P < 0·001 for IgG, IgG1 and IgG3; L. casei 431®, P < 0·001 for IgG1 and IgG3). Significantly greater mean fold increases for vaccine-specific secretory IgA in saliva were observed in both probiotic groups v. placebo (BB-12®, P = 0·017; L. casei 431®, P = 0·035). Similar results were observed for total antibody concentrations. No differences were found for plasma cytokines or innate immune parameters. Data herein show that supplementation with BB-12® or L. casei 431® may be an effective means to improve immune function by augmenting systemic and mucosal immune responses to challenge.

APA, Harvard, Vancouver, ISO, and other styles

48

Volokh, Olesya, Natalia Klimenko, Yulia Berezhnaya, Alexander Tyakht, Polina Nesterova, Anna Popenko, and Dmitry Alexeev. "Human Gut Microbiome Response Induced by Fermented Dairy Product Intake in Healthy Volunteers." Nutrients 11, no. 3 (March 4, 2019): 547. http://dx.doi.org/10.3390/nu11030547.

Full text

Abstract:

Accumulated data suggests that the gut microbiome can rapidly respond to changes in diet. Consumption of fermented dairy products (FDP) fortified with probiotic microbes may be associated with positive impact on human health. However, the extent and details of the possible impact of FDP consumption on gut community structure tends to vary across individuals. We used microbiome analysis to characterize changes in gut microbiota composition after 30 days of oral intake of a yoghurt fortified with Bifidobacterium animalis subsp. lactis BB-12. 16S rRNA gene sequencing was used to assess the gut microbial composition before and after FDP consumption in healthy adults (n = 150). Paired comparison of gut microbial content demonstrated an increase in presence of potentially beneficial bacteria, particularly, Bifidobacterium genus, as well as Adlercreutzia equolifaciens and Slackia isoflavoniconvertens. At a functional level, an increased capacity to metabolize lactose and synthesize amino acids was observed accompanied by a lowered potential for synthesis of lipopolysaccharides. Cluster analysis revealed that study volunteers segregated into two groups with post-intervention microbiota response that was dependent on the baseline microbial community structure.

APA, Harvard, Vancouver, ISO, and other styles

49

Panebianco, C., F. Bou Nasser Eddine, G. Forlani, G. Palmieri, L. Tatangelo, A. Villani, L. Xu, R. Accolla, and V. Pazienza. "Probiotic Bifidobacterium lactis, anti-oxidant vitamin E/C and anti-inflammatory dha attenuate lung inflammation due to pm2.5 exposure in mice." Beneficial Microbes 10, no. 1 (February 8, 2019): 69–75. http://dx.doi.org/10.3920/bm2018.0060.

Full text

Abstract:

The incidence of asthma and allergic diseases of the airways is constantly increasing, both in the industrialised and developing countries, due to harmful and excessive quantities of air pollution. Although some studies have shown an effect of dietary supplementation of specific nutrients (especially with anti-oxidant and anti-inflammatory properties) in reducing airways inflammatory response, the results are not yet conclusive and the science is still at its infancy. Our hypothesis is that combining such nutrients could provide more benefits than using them alone. The aim of the research project proposed here is to investigate whether specific combinations of nutrients (docosahexanoic acid, vitamin C and E, and Bifidobacterium lactis strain BB-12®, included in an engineered diet) can act synergistically to reduce inflammation given by high level of air pollution. Beside the role of docosahexanoic acid, vitamins C and E on airways inflammatory disease, no study examined the effect of the supplementation of this probiotic strain in pathological conditions caused by air pollution so far. Herein we used a well-established in vivo model for the study of pollution effects, which consists in female BALB/c mice receiving by pharyngeal aspiration either a sham or a particulate matter with diameter <2.5 μm (PM 2.5) containing aerosol. Before treatment, mice were fed either a chow or a supplemented diet. By performing histological analyses and gene expression profiles on lung sections and serum measurement of the cytokine interleukin 10, we found that a specific combination of all the aforementioned nutrients rather than nutrients alone had a synergistic protective effect against PM2.5-induced inflammation. In conclusion, our study support that a supplemental nutritional intervention based on a combination of the probiotic B. lactis BB-12, the anti-oxidant vitamin C and E, and the anti-inflammatory docosahexanoic acid represents a rational option for alleviating air pollution-related lung inflammation.

APA, Harvard, Vancouver, ISO, and other styles

50

Fijan, Sabina, Dunja Šulc, and Andrej Steyer. "Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against Escherichia coli." International Journal of Environmental Research and Public Health 15, no. 7 (July 20, 2018): 1539. http://dx.doi.org/10.3390/ijerph15071539.

Full text

Abstract:

Escherichia coli is an important commensal of our gut, however, many pathogenic strains exist, causing various severe infections in the gut or beyond. Due to several antibiotic resistance patterns of E. coli, research of alternative treatments or adjuvant therapy is important. One of these is the use of probiotics as antagonistic agents against E. coli. Most published studies investigate only one strain of E. coli and single-strain probiotics. The objectives of this study were to evaluate the antagonistic activity of selected single-strain and multi-strain probiotic supplements against selected clinical E. coli pathotypes using the in vitro agar spot test and the co-culturing method. Molecular methods were used to determine the presence of the genus lactobacilli and bifidobacteria as well as certain selected strains in the probiotic supplements. The agar-spot test showed that the multi-strain probiotics were more effective than the single-strain probiotics. On the other hand, the co-culturing method showed the opposite result, indicating that results are importantly influenced by the chosen method. The most effective single-strain probiotics against E. coli strains were Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus reuteri DSM 17938. The most effective multi-strain probiotics contained lactobacilli, bifidobacteria and enterococci strains, thus proving that most effective probiotics against E. coli strains are the lactic acid bacteria and bifidobacteria. The overall results from both in vitro tests reveal that all selected probiotics exhibited an antagonistic activity against all E. coli strains. From a public health perspective probiotics have thus proved to be successful in inhibiting the growth of E. coli and could therefore be used as adjuvant therapy or alternative therapy in E. coli infections.

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Bifidobacterium lactis (Bb-12)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles